Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2003, p. 5198-5207, Vol. 23, No. 15
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.15.5198-5207.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Zentrum Biochemie und Molekulare Zellbiologie, Abteilung Biochemie II,1 Abteilung Pathologie, Universität Göttingen,4 Abteilung Neurobiologie, Max-Planck Institut für Biophysikalische Chemie, Göttingen,3 Biochemisches Institut, Universität Kiel, Kiel, Germany3
Received 13 February 2003/ Accepted 26 April 2003
|
|
|---|
|
|
|---|
These trafficking events require budding of transport vesicles and fusion between membranes. SNARE proteins on both membranes are integral parts of the machinery required for recognition and fusion between membranes (11, 21). These SNAREs form complexes bridging the gap between the membranes. SNAREs are conserved in evolution and posses a common domain structure. Most SNAREs contain a C-terminal transmembrane domain. The conserved SNARE motif consists of 60 amino acid residues and is sufficient for SNARE complex formation. Four different SNARE motifs form an extended four-helix bundle (3, 40). Most amino acid side chains pointing into the interior of the bundle are hydrophobic. In the middle of the SNARE motif, however, the side chains of one arginine and three glutamine residues interact in a plane perpendicular to the axis of the helical bundle which is called the 0 layer. SNAREs can be subdivided into R-, Qa-, Qb-, and Qc-SNAREs according to 0-layer residues and further sequence homologies (7).
We are interested in SNAREs involved in endosomal trafficking. In yeast, a single Qb-SNARE, Vti1p, is utilized throughout the endosomal system as part of four different SNARE complexes. Vti1p is required for traffic from the Golgi to the endosome, for traffic to the vacuole (lysosome), for retrograde traffic to the cis-Golgi, and for homotypic TGN fusion (9, 15, 17). While Caenorhabditis elegans has one ortholog, Arabidopsis thaliana, Drosophila, and mammals express two proteins related to yeast Vti1p. Mammalian vti1a and vti1b share only 30% of their amino acid residues with each other, as well as with yeast Vti1p (1, 16, 27). vti1a and vti1b have different but overlapping subcellular localizations (25). vti1a is found mostly in the Golgi and TGN. vti1b is localized predominantly to endosomes, vesicles, and tubules in the TGN area and the TGN. Both proteins are part of distinct SNARE complexes. vti1a is in a complex with the R-SNARE VAMP-4, syntaxin 16 (Qa), and syntaxin 6 (Qc) (25, 28). vti1b complexes with endobrevin/VAMP-8, syntaxin 7 (Qa), and syntaxin 8 (Qc). vti1a and vti1b function in distinct trafficking steps, as indicated by antibody inhibition experiments in vitro. Antibodies directed against vti1a inhibit transport of vesicular stomatitis virus G protein through the Golgi (49), fusion of early endosomes (4), and transport from early and recycling endosomes to the TGN (28). Antibodies directed against vti1b inhibit fusion of late endosomes (4).
In this study, we inactivated the mouse gene coding for vti1b by targeted disruption to investigate the role of vti1b in the whole organism. Absence of vti1b resulted in reduced protein levels of one SNARE partner, syntaxin 8, but levels of endobrevin and syntaxin 7 remained unchanged. vti1b-deficient mice did not suffer from serious defects. However, some vti1b-deficient mice were smaller than their littermates. Lysosomal degradation of an endocytosed protein was slightly delayed, and multivesicular bodies and autophagic vacuoles accumulated in hepatocytes of some of these smaller mice.
|
|
|---|
![]() View larger version (28K): [in a new window] |
FIG. 1. Targeted disruption of vti1b. (A) Genomic DNA for vti1b isolated from a phage library. According to information from the Mouse Genome Sequencing Consortium, exon 1 encodes 100 bp of 5' untranslated region and amino acid residues 1 to 38 and exon 2 encodes amino acid residues 39 to 58. (B) Seven-kilobase targeting vector with exon 4 disrupted by insertion of the neomycin resistance cassette (neo). (C) vti1b locus after homologous recombination. Sections of DNA used as probes for Southern blot hybridizations are marked, and fragments detected after EcoRI and XbaI digestions are indicated for the targeted and wild-type (A) alleles. (D) Southern blots of ES cell DNA after EcoRI and XbaI digestions. An EcoRI fragment of 4.0 kb is detected in the wild-type (+/+) allele, and a 4.8-kb band is detected in the targeted allele. Insertion of the neo gene reduces an 8-kb wild-type XbaI fragment to 7 kb.
|
Western blot analysis. Tissue homogenates of liver, brain, kidney, and spleen were prepared by homogenization in lysis buffer (1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 5 mM iodoacetic acid in Tris-buffered saline [TBS] containing 150 mM NaCl and 50 mM Tris-HCl, pH 7.4) in an Ultra-Turrax homogenizer. Cultivated hepatocytes and mouse embryonic fibroblasts (MEFs) were scraped off in TBS with 0.1% Triton X-100 and sonicated for 3 s. One milligram of protein from liver homogenate was extracted with Triton X-114 (8), and the detergent fraction was concentrated by acetone precipitation to enrich membrane proteins and to facilitate detection of endobrevin. Twenty micrograms of total protein was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and subjected to immunoblotting using enhanced chemiluminiscence (Pierce, Rockford, Ill.). Polyclonal antisera directed against vti1a, vti1b, SNAP-29, syntaxin 7, syntaxin 8, and endobrevin were described previously (4, 6, 14).
Northern blotting.
Total RNA was isolated from brain and kidney using the RNeasy kit (Qiagen, Hilden, Germany). Ten micrograms of total RNA was separated on an agarose formaldehyde gel and transferred onto a Hybond-N membrane (Amersham, Braunschweig, Germany). cDNA probes were labeled with [
-32P]dCTP using the Megaprime DNA-labeling kit (Amersham). The membranes were hybridized with labeled vti1b cDNA in RapidHyb hybridization solution (Amersham) according to the manufacturer's instructions. Hybridization with a syntaxin 8 cDNA probe encoding the cytoplasmic domain (4) was performed in the following buffer: 48% (vol/vol) formamide, 125 mM NaCl, 12.5 mM trisodium citrate, 1% SDS, 10 mM Tris-HCl (pH 7.5), and 10% dextran sulfate in Denhardt's solution at 42°C.
Syntaxin 8 immunoprecipitation and stabilization in MEFs.
MEF lines were established from day 13.5 embryos by continuously passaging the cells (42). MEFs were plated onto 3-cm-diameter plastic culture dishes and kept in culture till they reached
50% confluency. To immunoprecipitate newly synthesized syntaxin 8, the cells were washed twice with phosphate-buffered saline (PBS) and incubated for 12 or 24 h with 200 µCi of [35S]methionine/ml in Dulbecco's modified Eagle medium without methionine and containing 5% dialyzed fetal calf serum. After being labeled, the cells were washed twice with PBS at 4°C, scraped off in 400 µl of TBS plus 0.1% Triton X-100 supplied with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 5 mM iodoacetic acid, 1 mM EDTA), sonicated, and centrifuged. The supernatants were preabsorbed with protein A-Sepharose and incubated with 4 µl of antiserum directed against syntaxin 8 at 4°C overnight and for an additional 2 h after the addition of 50 µl of protein A-Sepharose. The pellet was washed five times with lysis buffer, and the proteins were eluted with 60 µl of 2x stop buffer and separated by SDS-PAGE.
To inhibit lysosomal proteases, MEFs on 3-cm-diameter plastic culture dishes were incubated for 8 or 16 h in medium with or without 100 µM leupeptin and scraped off in 500 µl of PBS with 0.1% Triton X-100. Syntaxin 8 and vti1a protein levels were checked by immunoblotting.
Activities of lysosomal enzymes in tissue homogenates. Homogenates of tissues (adjusted to 0.05% Triton X-100) were assayed for ß-hexosaminidase, ß-mannosidase, and ß-glucuronidase using 4-methylumbelliferyl substrates (24). Arylsufatase A was measured using p-nitrocatechol sulfate as a substrate (34). The measurements were done in a fluorescence spectrophotometer at 365-nm excitation and 410-nm emission wavelength. The measured values were corrected with the help of 4-methylumbelliferone solution as a reference. The activities of enzymes in homogenates were calculated as milliunits per gram of tissue.
Preparation of primary mouse hepatocytes. Mouse hepatocytes from 10- and 15-month-old vti1b-deficient and wild-type mice were prepared using a collagenase-independent method described previously (29). The cells were enriched using a Percoll gradient (58% [wt/vol]) and plated on gelatin-treated plastic culture dishes at 6.5 x 105 per 3-cm-diameter dish. The hepatocytes were cultured overnight in RPMI 1640 containing 10% fetal calf serum and penicillin-streptomycin (Gibco) before the experiments.
Uptake and degradation of 125I-asialofetuin in hepatocytes. 125I-asialofetuin degradation was measured as described previously (44). Asialofetuin was iodinated using IODO-Gen tubes (Pierce) according to the manufacturer's instructions. Hepatocytes were serum starved in RPMI with 0.1% bovine serum albumin for 4 h and incubated with 10 nM 125I-asialofetuin in RPMI with 0.1% bovine serum albumin (600 µl; 120,000 cpm) for 20 min. The plates were washed once and supplemented with new medium for the appropriate chase periods. At the end of each incubation, the medium was collected and the cells were scraped off in PBS plus 0.2% Triton X-100. The medium and the cell lysates were precipitated with 10% trichloroacetic acid (TCA) for 10 min on ice. TCA pellets were obtained by centrifugation and dissolved in 0.5 M NaOH. The soluble (degraded 125I-asialofetuin) and insoluble (intact proteins) radioactivities in the medium and cells were measured in a gamma counter. The rates of lysosomal degradation were calculated as percentages of soluble radioactivity in relation to the sum of precipitated cellular 125I-asialofetuin and soluble radioactivity for each time point.
Electron microscopy. Ultrathin cryosections were prepared as described previously (43). Hepatocytes were fixed with 2% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M sodium phosphate, pH 7.4, for 30 min at room temperature directly on cell culture dishes. The cells were postfixed with 4% paraformaldehyde and 0.1% glutaraldehyde for 2 h on ice and removed from the dishes with a cell scraper. After being washed twice with PBS- 0.02% glycine, the cells were embedded in 10% gelatin, cooled on ice, and cut into small blocks. The blocks were infused with 2.3 M sucrose overnight and stored in liquid nitrogen. For immunolabeling, ultrathin sections were incubated with antibodies against LAMP-1 (1:30), followed by protein A-gold (10-nm diameter). Sections were contrasted with uranyl acetate-methyl cellulose for 10 min on ice, embedded in the same solution, and examined with a Phillips CM120 electron microscope.
The isolated hepatocytes were fixed in 2% glutaraldehyde in 0.2 M HEPES, pH 7.4, for 2 h. The cells were scraped off the culture dish, stored in 0.2 M HEPES, pH 7.4, postfixed in 1% OsO4 for 1 h, dehydrated in ethanol, and embedded in Epon. Autophagosome profiles were counted under the microscope. The cell area was estimated by point counting, using negatives taken at x400 magnification. Three separate grid openings were counted from each sample.
|
|
|---|
![]() View larger version (28K): [in a new window] |
FIG. 2. vti1b mRNA and protein were absent in animals homozygous for the targeted vti1b allele. (A) Genotyping of genomic DNA using PCR. A band of 500 bp including exon 4 of vti1b was amplified from the wild-type (WT) allele. After insertion of the neo gene, the fragment shifts to 1,600 bp. In addition, the neo gene was amplified using specific primers (not shown). (B) Northern blot for vti1b mRNA. RNA was isolated from the brains and kidneys of wild-type (+/+) and vti1b-deficient (-/-) animals, separated by agarose gel electrophoresis, blotted, and probed for vti1b. (C) Western blot for vti1b protein. Protein extracts from wild-type, heterozygous (+/-), and vti1b-deficient embryonic fibroblasts were separated by SDS-PAGE and stained with an antiserum directed against vti1b. The vti1b protein was not detected in vti1b-/- cells. Less vti1b was present in heterozygous than in wild-type cells.
|
![]() View larger version (28K): [in a new window] |
FIG. 3. Syntaxin 8 protein levels are reduced in vti1b-deficient mice. Homogenates were prepared from livers, brains, kidneys, and spleens of wild-type (+/+), heterozygous (+/-), and vti1b-deficient (-/-) animals; separated by SDS-PAGE; and stained with antisera directed against the indicated SNAREs. Liver homogenates from wild-type and vti1b-deficient animals were extracted with Triton X-114, and the detergent phase was separated by SDS-PAGE to allow the detection of endobrevin. No reduction in protein levels was observed for endobrevin, syntaxin 7, vti1a, and SNAP-29.
|
![]() View larger version (74K): [in a new window] |
FIG. 4. Syntaxin 8 mRNA was stable in vti1b-deficient mice, but the syntaxin 8 protein was degraded in lysosomes. (A) Similar levels of syntaxin 8 mRNA were detected in wild-type and vti1b-deficient mice. RNA was isolated from the kidneys of wild-type (+/+) and vti1b-deficient (-/-) animals, separated by agarose gel electrophoresis, blotted, and probed for syntaxin 8. (B) Syntaxin 8 protein was slowly synthesized in wild-type embryonic fibroblasts. Wild-type (+/+) and vti1b-deficient (-/-) embryonic fibroblasts were incubated with [35S]methionine for 12 or 24 h. Syntaxin 8 was immunoprecipitated, and the fractions were analyzed by SDS-PAGE and autoradiography. Even though syntaxin 8 protein could be precipitated, incorporation of radioactivity was detected only after 24 h (arrow), indicating that the protein is very stable. The upper band at 29 kDa was nonspecific. (C) Treatment with the lysosomal protease inhibitor leupeptin stabilized syntaxin 8 protein in vti1b-deficient fibroblasts. vti1b-deficient (-/-) and wild-type (+/+) embryonic fibroblasts were treated with 100 µM leupeptin as indicated. Extracts containing equal amounts of protein were analyzed by immunoblotting, using antiserum directed against syntaxin 8 or vti1a as a loading control. un, untreated; L, leupeptin.
|
Heterogeneity of phenotypes among vti1b-deficient mice. We noticed that some vti1b-deficient mice were smaller than their littermates. The weights of mice from the same litter and of the same sex were compared (Fig. 5). All mice gained weight at similar rates until days 16 to 18. Around this time, pups start to feed on a solid diet. Afterward, some vti1b-deficient mice lost weight and remained lighter than their littermates. A few small mice even died at an age between 3 and 5 weeks (Fig. 5, left). Twenty-two percent (33 out of 149) of the vti1b-deficient mice were considerably smaller than their littermates, two-thirds of them males (21). These mice had considerably less fat tissue than other mice of the same age.
![]() View larger version (18K): [in a new window] |
FIG. 5. vti1b-deficient mice showed a heterogeneous growth phenotype. Male mice from the same litter were compared. All of the mice gained weight at similar rates until day 16. Afterward, a few died (left, solid diamonds), and 20% of the vti1b-deficient mice lost weight and remained smaller than their littermates (left, shaded circles and solid triangles; right, solid circles). Most vti1b-deficient mice (right, solid squares and diamonds) grew at rates similar to those of their heterozygous (right, open symbols) or wild-type (left, open symbols) littermates.
|
![]() View larger version (130K): [in a new window] |
FIG. 6. Liver cysts in aged normal-size vti1b-deficient mice. Eight out of 23 vti1b-deficient mice between 15 and 21 months old had multiple liver cysts (arrows). These cysts were filled with a clear fluid, except for two small cysts containing a yellow liquid. gb, gall bladder.
|
![]() View larger version (22K): [in a new window] |
FIG. 7. Levels of lysosomal hydrolases were not affected by deletion of vti1b. The activities (in milliunits per gram of tissue) of the lysosomal hydrolases arylsulfatase A, ß-hexosaminidase, ß-mannosidase, and ß-glucuronidase were determined in liver homogenates derived from wild-type (+/+; n = 5), normal-size (n = 3), and small (n = 2) vti1b-deficient (-/-) mice. The error bars indicate standard deviations.
|
![]() View larger version (30K): [in a new window] |
FIG. 8. Lysosomal degradation of endocytosed 125I-asialofetuin was slower in hepatocytes derived from small vti1b-deficient mice. No difference in degradation of 125I-asialofetuin was observed in hepatocytes from wild-type (+/+) and vti1b-deficient (-/-) mice of normal weight. Hepatocytes derived from wild-type or vti1b-deficient mice of normal or smaller size were cultured for 1 day. They were incubated with 125I-asialofetuin for 20 min at 37°C and chased for the indicated periods after removal of the radioactive medium. Degraded (soluble in TCA) and intact 125I-asialofetuins were separated by TCA precipitation of the medium and cells and quantified. About 8,000 to 18,000 cpm was endocytosed by the hepatocytes, depending on cell density but independent of the genotype. Three individual experiments were performed with double values. The error bars indicate standard deviations.
|
Hepatocytes from a wild-type mouse and three smaller vti1b-deficient mice were used to quantify the accumulation of autophagic vacuoles on ultrathin Epon sections. In hepatocytes derived from two of the small vti1b-/- mice, a strong accumulation of both early (Avi) and late (Avd) autophagic vacuoles was observed (Fig. 9A). An increased proportion of these autophagic vacuoles were connected to each other, suggesting that they might have been caught in the process of fusion (Fig. 9B). In addition, more multivesicular bodies were present. However, autophagic vacuoles did not accumulate in hepatocytes from the third small vti1b-deficient mouse, further emphasizing the variability in phenotypes.
![]() View larger version (115K): [in a new window] |
FIG. 9. Hepatocytes of some smaller vti1b-deficient mice accumulated autophagic vacuoles and multivesicular bodies. (A) The numbers of early (Avi) and late (Avd) autophagic vacuole profiles per 100 µm2 of cell area on thin sections were determined for hepatocytes isolated from wild-type (wt) and three different smaller vti1b-deficient (Ko) mice. The error bars represent standard errors of the mean. (B) Fusion profiles of autophagic vacuoles (arrows), as well as multivesicular bodies (*), were more prominent in hepatocytes from vti1b-/- mouse 101 (left) than in wild-type (right) hepatocytes. G, Golgi. Bar, 500 nm.
|
![]() View larger version (118K): [in a new window] |
FIG.10. LAMP-1-positive structures had similar appearances in wild-type (WT) and vti1b-deficient hepatocytes. Ultrathin cryosections were obtained from hepatocytes of wild-type and smaller vti1b-deficient mice and were decorated with antibodies specific for LAMP-1 and 10-nm-diameter protein A-gold. LAMP-1 is found in lysosomes, late endosomes, and late autophagic vacuoles. vti1b-/- cells seemed to contain more LAMP-1-positive organelles, which were sometimes clustered. Bar, 1 µm.
|
|
|
|---|
Defects and phenotypic variability in vti1b-deficient mice. Twenty percent of the vti1b-deficient mice had lower body weights than their littermates, especially around the time of weaning, at an age of 3 to 5 weeks. The mortality of the smaller mice increased during this period. Anatomical abnormalities were detected in the liver and gall bladder. Eighteen percent of smaller vti1b-/- mice had enlarged gall bladders. Multiple liver cysts were found in a third of normal-size vti1b-/- mice older than 15 months. Therefore, hepatocytes were used to study lysosomal function and morphology. Lysosomal degradation of an endocytosed protein, asialofetuin, was slightly delayed in hepatocytes isolated from smaller vti1b-deficient mice but was not affected in hepatocytes derived from normal-size vti1b-deficient mice. These data fit with electron microscopical analysis of hepatocytes. Hepatocytes derived from normal-size vti1b-deficient mice were indistinguishable from wild-type hepatocytes. An accumulation of multivesicular endosomes and autophagic vacuoles was observed in hepatocytes isolated from some of the smaller vti1b-deficient mice, but this finding was not consistent. In addition, more multivesicular endosomes and autophagic vacuoles were observed in close contact with each other or seemed to be in the process of fusion. These data indicate that fusion of these organelles may be slowed down. However, the effect was not strong enough to severely impact lysosomal function. Mice lacking the lysosomal membrane protein LAMP-2 accumulate autophagic vacuoles in hepatocytes (41) due to the prolonged half-life of early and late autophagic vacuoles (13). However, they do not accumulate multivesicular endosomes or fusion profiles, indicating that LAMP-2 and vti1b function in distinct molecular steps.
The phenotypic variability of vti1b-deficient mice may be due to the mixed genetic background of these mice. The embryonic stem cells were derived from mouse strain 129/SvJ. Chimeric animals were crossed with C57BL/6J mice. The offspring of this cross were bred further to obtain the animals used in this study. Variations in phenotype are also observed in other knockout mice. About 50% of mice deficient for the lysosomal membrane protein LAMP-2 die between postnatal days 20 and 40, while the rest are long-term survivors (41).
Compensation for vti1b deficiency. The mild phenotypes suggest that the loss of vti1b is compensated for. As vti1b is a Qb-SNARE, another Qb-SNARE is needed to replace it. The best candidate is vti1a, because it is the closest relative of vti1b, even though the proteins share only 30% of their amino acid residues.
Mice deficient for the R-SNARE VAMP-3/cellubrevin are the only examples of compensation for the loss of a SNARE (51). VAMP-2/synaptobrevin 2 probably substitutes for VAMP-3, as the two proteins share 74% of their amino acid residues, differ only in a single residue in the SNARE motif, and are coexpressed in nonneuronal tissues (36). By contrast, the loss of syntaxin 4 results in embryonic lethality (50), even though syntaxin 2 and syntaxin 3 share 44 and 41% of their amino acid residues, respectively, with syntaxin 4. These three proteins are coexpressed and are predominantly present on the plasma membrane but differ in their distributions between apical and basolateral domains in polarized cells (26).
According to sequencing projects, the only additional known mammalian Qb-SNAREs with a single SNARE motif are membrin and GOS-28, which are involved in endoplasmic reticulum-to-Golgi and intra-Golgi traffic (18, 31). They are unlikely candidates for replacing vti1b because of their subcellular localization and low sequence homology.
The compensatory protein did not stabilize the Qc-SNARE syntaxin 8, since amounts of syntaxin 8 were strongly reduced in all vti1b-deficient mice. vti1a forms a SNARE complex including the Qc-SNARE syntaxin 6. As the closest relative, syntaxin 6 may compensate for the loss of syntaxin 8, since both proteins occupy the same position in a SNARE complex. However, syntaxin 6 and syntaxin 8 share only 23% of their amino acid residues (39). A candidate for substituting for both vti1b and syntaxin 8 is SNAP-29, which contains a Qb- and a Qc-SNARE motif. SNAP-29 has been localized to the Golgi and binds several syntaxins, preferentially syntaxin 6 (39, 47, 48), but its function is not known. A complex containing endobrevin, syntaxin 6, and SNAP-29 was immunoprecipitated upon overexpression of all components (19). This complex contains an R-SNARE, a Qb-SNARE, and two Qc-SNARE motifs, but no Qa-SNARE, distinguishing it from all well-characterized SNARE complexes found in vivo under endogenous expression levels.
Another reason for the lack of phenotype in vti1b-deficient mice could be the existence of a redundant SNARE complex. The R-SNARE VAMP-7 functions in fusion with the lysosome (2, 46). VAMP-7 forms a complex with syntaxin 7 (45). The Qb- and Qc-SNAREs of this complex are not known, but vti1b plus syntaxin 8 or SNAP-29 is the best candidate among the known SNAREs.
In summary, three different compensatory mechanisms are most likely: the presence of a distinct SNARE complex containing VAMP-7 or replacement of vti1b and syntaxin 8 in an endobrevin- and syntaxin 7-containing SNARE complex either by vti1a and syntaxin 6 or by SNAP-29.
This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 523 and TP B7 and Z2) and from the Volkswagen Stiftung (Nachwuchsgruppen an Universitäten program).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»